E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/11/2013 in the Prospect News PIPE Daily.

Skinvisible completes $1 million private placement of 9% convertibles

Deal funds general working capital; notes will mature on various dates

By Devika Patel

Knoxville, Tenn., Jan. 11 - Skinvisible, Inc. sold $1 million of convertible promissory notes between Sept. 14 and Dec. 31, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

The 9% notes are due at various times from Sept. 14, 2014 to Dec. 13, 2014 and may be converted into common shares at 90% of the average trading prices of the stock during the five trading days preceding the conversion date.

Proceeds will be used for general working capital purposes.

Skinvisible is a Las Vegas research and development company that has formulated and patented innovative polymer delivery system technology and compositions for topical skin applications.

Issuer:Skinvisible, Inc.
Issue:Convertible promissory notes
Amount:$1 million
Maturity:Various times from Sept. 14, 2014 to Dec. 13, 2014
Coupon:9%
Conversion price:90% of the average trading prices of the stock during the five trading days preceding the conversion date
Warrants:No
Settlement date:Sept. 14 through Dec. 31
Stock symbol:OTCBB: SKVI
Stock price:$0.03 at close Sept. 13
Market capitalization:$3.7 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.